arrow
V

Volker Budach

Charité - Universitätsmedizin Berlin
H指数:69
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploratory immunomonitoring during radiochemotherapy in HNSCC and machine-learning reveal immune parameters associated with disease-free survival

头颈鳞状细胞癌放疗期间的探索性免疫监测与机器学习揭示与无病生存期相关的免疫参数

2026-08-310
OA
Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I–III breast cancer

欧洲癌症研究与治疗组织22922/10925随机试验二十年结果:评估I-III期乳腺癌患者胸骨内链和锁骨上内侧淋巴结照射效果

2026-05-160
OAAI
Integrating MALDI-MSI-Based Spatial Proteomics and Machine Learning to Predict Chemoradiotherapy Outcomes in Head and Neck Cancer

整合基于MALDI-MSI的空间蛋白质组学与机器学习以预测头颈癌的放化疗效果

2025-09-210
OAAI
The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies
2024-12-011
PRE
De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial)
2024-08-193
OAAI
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing De fi nitive Chemoradiation
2024-04-013
OAAI
Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: Results from EORTC 22922/ 10925
2023-08-015
PRE
FLASHlab @PITZ: New R&D platform with unique capabilities for electron FLASH and VHEE radiation therapy and radiation biology under preparation at PITZ
2022-12-0122
PRE
Treatment Planning for Cardiac Radioablation: Multicenter Multiplatform Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial

心脏放射消融的治疗计划: 室性心动过速放射外科 (RAVENTA) 试验的多中心多平台基准测试

2022-10-0111
PRE
The association of internal mammary and medial supraclavicular lymph node radiation technique with clinical outcomes: Results from the EORTC 22922/10925 randomised trial

内乳和锁骨上内侧淋巴结放射技术与临床结果的关系: 来自EORTC 22922/10925随机试验的结果

2022-07-0123
PRE
18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization

头颈癌的18f-氟脱氧葡萄糖正电子发射断层扫描: 潜在治疗个性化的位置和HPV特定参数

2022-06-086
OAAI
Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy

术后放疗 (化疗) 治疗的HPV阴性局部晚期HNSCC患者局部区域控制预后的6基因签名的开发和验证

2022-06-016
PRE
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapy

HPV阴性HNSCC患者术后放化疗的分子亚型分析及其与放射抵抗机制的关系

2022-02-015
PRE
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy

肿瘤DNA-甲基化组衍生的表观遗传指纹识别HPV阴性头颈部患者术后放化疗后局部复发的风险

2021-11-082
OAAI
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
2021-07-3111
OAAI